CyberKnife Society Receives Record Registration for 7th Annual CyberKnife Users' Meeting

More than 500 Healthcare Specialists to Convene in Arizona to Share Expertise

SUNNYVALE, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 500 medical, clinical and technical specialists have registered for the 7th Annual CyberKnife Users' Meeting, January 23-27, 2008 in Scottsdale, Ariz.

Over the past seven years, Accuray has seen consistent growth in the number of users attending the meeting, beginning with just 27 users at the first meeting in 2001. The 7th Annual Meeting demonstrated not only record registration, but also a record number of presentation and poster abstracts submitted for consideration.

"We're thrilled with the tremendous amount of interest we've received around this year's Users' Meeting from presenters and attendees alike," said Eric P. Lindquist, senior vice president and chief marketing officer of Accuray Incorporated. "Taking into account clinicians' busy schedules, we feel the robust attendance anticipated at this year's Users' Meeting shows the clinical value of the event and the growing role CyberKnife radiosurgery is playing in cancer care."

Unlike many other technologies' Users' meetings, the CyberKnife Users' Meeting is uniquely focused on delivering concentrated clinical material presented by CyberKnife users in various fields. For this reason a maximum of 26 continuing medical education (CME) credits(TM), accredited through Georgetown University Hospital, will be offered to participating physicians.

This year's meeting will feature more than 70 clinical and technical presentations selected by a scientific panel of users, as well as more than 70 scientific posters, focusing on intracranial and extracranial experience and treatment outcomes from CyberKnife users worldwide. In addition, specialized sessions will be offered focusing on coding and reimbursement, business development and marketing, patient management and efficiencies, and physics, along with tumor review board interactive panel discussions.

The CyberKnife Users' Meeting is organized by the CyberKnife Society, an organization that brings together users from around the world to foster the scholarly exchange of information pertaining to CyberKnife radiosurgery. Attendees include leading surgeons, radiation oncologists, radiation therapists, physicists, administrators and nurses from around the world. Attendance at the CyberKnife Users' Meeting is typically self-funded for both attendees and presenters alike.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 100 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

CME Statement

Georgetown University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Georgetown University Hospital designates this educational activity for a maximum of 26 hours AMA PRA Category 1 Credits(TM). Each physician should claim only those hours of credit that he/she actually spent in the education activity.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, clinical studies, regulatory review and approval, and commercialization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-Q for the quarterly period ended September 29, 2007 and may be updated from time to time by our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

SOURCE Accuray Incorporated
01/15/2008
CONTACT: Susan Lehman of Rockpoint Public Relations, +1-510-832-6006,
susan@rockpointpr.com, for Accuray; or Stephanie Tomei, Public Relations
Manager of Accuray Incorporated, +1-408-789-4234, stomei@accuray.com
Web site: http://www.accuray.com